Literature DB >> 840277

Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

P R Craddock, J Fehr, K L Brigham, R S Kronenberg, H S Jacob.   

Abstract

During hemodialysis, cardiopulmonary decompensation may appear in uremic patients, possibly caused by plugging of pulmonary vessels by leukocytes. In 34 patients we noted leukopenia (20% of initial levels) during hemodialysis that in 15 was associated with impaired pulmonary function. When we infused autologous plasma, incubated with dialyzer cellophane, into rabbits and sheep, sudden leukopenia and hypoxia occurred, with doubling of pulmonary-artery pressures and quintupling of pulmonary-lymph effluent. Histologic examination showed severe pulmonary-vessel-leukostasis and interstitial edema. The syndrome was prevented by preinactivation of complement but was reproduced by infusions of plasma in which complement was activated by zymosan. Thus, acute pulmonary dysfunction from complement-mediated leukostasis may play a major part in the acute cardiopulmonary complications of cellophane-membrane hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 840277     DOI: 10.1056/NEJM197704072961401

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  114 in total

1.  Pathogenesis of Purtscher's retinopathy. An experimental study.

Authors:  W Behrens-Baumann; G Scheurer; H Schroer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  Pulmonary function in chronic renal failure: effects of dialysis and transplantation.

Authors:  A Bush; R Gabriel
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

3.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

Review 4.  Effect of uremia and its treatment on pulmonary function.

Authors:  D J Prezant
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Lipid peroxidation and lung ultrastructural changes in an experimental model of leukocyte-mediated pulmonary injury.

Authors:  E Borrelli; P Giomarelli; O Chiara; A Casini; S Betti; L Sabatini; L Lorenzini; A Grossi
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 6.  Vascular occlusion of the retina: an experimental model. I. Leukocyte aggregates.

Authors:  G Scheurer; G Praetorius; B Damerau; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor.

Authors:  M Katoh; K Shikoshi; M Takada; M Umeda; T Tsukahara; S Kitagawa; T Shirai
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

8.  Changes in neutrophil surface phenotype during hemodialysis.

Authors:  K M Skubitz; J Butterfield; K Ma; A P Skubitz
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

9.  Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro.

Authors:  K M Skubitz; P R Craddock; D E Hammerschmidt; J T August
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

10.  Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.

Authors:  M Fung; M Lu; H Fure; W Sun; C Sun; N Y Shi; Y Dou; J Su; X Swanson; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.